eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
Published 4 months ago • 2.8K plays • Length 3:53Download video MP4
Download video MP3
Similar videos
-
5:27
eli lilly's drop after earnings is a buying opportunity, says mizuho's jared holz
-
9:35
eli lilly's miss explanation is 'totally opaque', says jim cramer
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
3:15
mounjaro remains the single largest driver for eli lilly stock in the near term: mizuho's jared holz
-
1:47
promising data from eli lilly shows a significant slowdown in the pace of alzheimer's
-
0:51
fda advisers say eli lilly's alzheimer's treatment is effective
-
3:13
eli lilly ceo: we see a path to an alzheimer's disease-modifying drug
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
5:47
fda advisers say eli lilly alzheimer's treatment is effective
-
6:48
eli lilly's alzheimer's drug slowed cognitive decline in phase 3 study
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
7:44
top analysts weigh in on apple and amazon's earnings
-
6:42
the economic data this week were all surprising to the upside, says natwest's michelle girard
-
8:42
undecideds, independents, even some gop voters turned off by trump's rhetoric: harris adviser
-
5:53
eli lilly and novo nordisk will remain leaders in the weight-loss drug market: mizuho's jared holz
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data
-
4:08
weight loss drug market is just beginning to take off, says mizuho's jared holz
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
6:08
eli lilly's dtc obesity drug push 'not necessarily an industry game changer': mizuho's jared holz
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz